# Sten Madsbad

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/sten-madsbad/

## Facts

| Field | Value |
| --- | --- |
| Citations | 37,976 |
| Field | Diabetes Treatment and Management |
| h-index | 101 |
| i10-index | 434 |
| Last Known Institution | University of Copenhagen |
| OpenAlex ID | https://openalex.org/A5062239390 |
| ORCID iD | https://orcid.org/0000-0002-5017-1815 |
| Works | 807 |

## Researcher papers

- [Angiotensin-Receptor Blockade versus Converting–Enzyme Inhibition in Type 2 Diabetes and Nephropathy](https://scholariq.org/papers/angiotensin-receptor-blockade-versus-converting-enzyme-inhibition-in-type-2/)
- [Reduced Postprandial Concentrations of Intact Biologically Active Glucagon-Like Peptide 1 in Type 2 Diabetic Patients](https://scholariq.org/papers/reduced-postprandial-concentrations-of-intact-biologically-active-glucagon-like/)
- [3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial](https://scholariq.org/papers/3-years-of-liraglutide-versus-placebo-for-type-2-diabetes-risk-reduction-and/)
- [Incretin Secretion in Relation to Meal Size and Body Weight in Healthy Subjects and People with Type 1 and Type 2 Diabetes Mellitus](https://scholariq.org/papers/incretin-secretion-in-relation-to-meal-size-and-body-weight-in-healthy-subjects/)
- [Liraglutide, a Long-Acting Human Glucagon-Like Peptide-1 Analog, Given as Monotherapy Significantly Improves Glycemic Control and Lowers Body Weight Without Risk of Hypoglycemia in Patients With Type 2 Diabetes](https://scholariq.org/papers/liraglutide-a-long-acting-human-glucagon-like-peptide-1-analog-given-as/)
- [Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial](https://scholariq.org/papers/efficacy-and-safety-of-oral-semaglutide-in-patients-with-type-2-diabetes-and/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)
- [Diet and metabolism studies](https://scholariq.org/topics/diet-and-metabolism-studies/)

## Researcher university

- [University of Copenhagen](https://scholariq.org/institutions/university-of-copenhagen/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.